Two years into reverse vaccinology

Vaccine

Volumn 21, Issue 7-8, 2003, Pages 605-610

  Adu Bobie, Jeannette ^a   Capecchi, Barbara ^a   Serruto, Davide ^a   Rappuoli, Rino ^a   Pizza, Mariagrazia ^a  

^a CHIRON VACCINES   (Italy)

Author keywords

Neisseria meningitidis B; Reverse Vaccinology; Vaccines

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; VACCINE;

BACTERIAL GENOME; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; DISSECTION; DRUG RESEARCH; GENOMICS; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MENINGITIS; METHODOLOGY; MICROORGANISM; NEISSERIA MENINGITIDIS; OPEN READING FRAME; OTITIS; PERIODONTITIS; PNEUMONIA; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BACTERIAL VACCINES; BIOTECHNOLOGY; GENOME, BACTERIAL; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MENINGOCOCCAL VACCINES;

EID: 0037472445     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00566-2     Document Type: Conference Paper

References (19)

1. Andre F.E. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine. 8(Suppl):1990;S74-78. discussion S79-80.
2. Greco D., Salmaso S., Mastrantonio P.et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N. Engl. J. Med. 334(6):1996;341-348.
3. Pizza M., Covacci A., Bartoloni A.et al. Mutants of pertussis toxin suitable for vaccine development. Science. 246(4929):1989;497-500.
4. Gardner M.J., Hall N., Fung E.et al. Genome sequence of the human malaria parasite Plasmodium talciparum. Nature. 419(6906):2002;498-511.
5. Tettelin H., Saunders N.J., Heidelberg J.et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science. 287(5459):2000;1809-1815.
6. Pizza M., Scarlato V., Masignani V.et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science. 287(5459):2000;1816-1820. [see comments].
7. Jennings G.T., Savino S., Marchetti E.et al. GNA33 from Neisseria meningitidis serogroup B encodes a membrane-bound lytic transglycosylase (MltA). Eur. J. Biochem. 269(15):2002;3722-3731.
8. Granoff D.M., Moe G.R., Giuliani M.M.et al. A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis. J. Immunol. 167(11):2001;6487-6496.
9. Comanducci M., Bambini S., Brunelli B.et al. NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195(11):2002;1445-1454.
10. St. Geme J.W., Cutter D., Barenkamp S.J. Characterization of the genetic locus encoding Haemophilus influenzae type b surface fibrils. J. Bacteriol. 178(21):1996;6281-6287.
11. Ogawa J., Keneko H., Masuda T., Nagata S., Hosoya H., Watanabe K. Novel adhesion molecules in the Contactin/F3 subgroup of the immunoglubulin superfamily: isolation and characterization of cDNAs from rat brain. Neurosci. Lett. 218(3):1996;173-176.
12. Scarselli M., Rappuoli R., Scarlato V. A common conserved amino acid motif module shared by bacterial and intercellular adhesions: bacterial adherence mimicking cell-cell recognition? Microbiology. 147:2001;250-252.
13. Wizemann T.M., Heinrichs J.H., Adamou J.E.et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun. 69(3):2001;1593-1598.
14. Ross B.C., Czajkowski L., Hocking D.et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine. 19(30):2001;4135-4142.
15. Montigiani S., Falugi F., Scarselli M.et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect. Immun. 70(1):2002;368-379.
16. Etz H., Minh D.B., Henics T.et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 99(10):2002;6573-6578.
17. Cafaro A., Caputo A., Maggiorella M.T.et al. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine. J. Med. Primatol. 29(3/4):2000;193-208.
18. Osterhaus A.D., van Baalen C.A., Gruters R.A.et al. Vaccination with Rev and Tat against AIDS. Vaccine. 17(20/21):1999;2713-2714.
19. Pauza C.D., Trivedi P., Wallace M.et al. Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Natl. Acad. Sci. U.S.A. 97(7):2000;3515.